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Abstract
Objective. The purpose of this study was to compare the effi-
cacy of the treatment of tinnitus with a phase-shifting pure
tone to that of the same tone treatment without phase shifting.
Study Design. A double-blind crossover randomized con-
trolled trial.
Setting. This study was conducted at the University Medical
Center Groningen.
Subjects and Methods. Twenty-two patients with predomi-
nantly tonal tinnitus underwent both intervention and
control treatments. Each treatment consisted of three 30-
minute sessions in 1 week. The control treatment was iden-
tical to the intervention treatment, except that the stimulus
was a pure tone without phase shifting. Questionnaires, tin-
nitus loudness match, and annoyance and loudness ratings
were used to measure treatment effects.
Results. Pure-tone treatment and phase-shift treatment had
no significant effect on tinnitus according to questionnaires
(Tinnitus Handicap Index, Tinnitus Reaction Questionnaire,
Hospital Anxiety and Depression Scale, and Maastricht
Questionnaire), audiological matching procedures, and
loudness and annoyance ratings of tinnitus. Furthermore,
phase-shift treatment showed no additional significant
improvement in comparison with pure-tone treatment.
Changes in questionnaire scores due to pure-tone and the
phase-shift treatment were correlated.
Conclusion. On average across the group, both treatments
failed to demonstrate a significant effect. Both treatments
were beneficial for some patients. However, a positive effect
was not demonstrated that could be attributed to the peri-
odic shifting of the phase of the stimulus tone.
Keywords
tinnitus, therapy, residual inhibition, phase shift, RCT
Received November 3, 2011; revised February 21, 2012; accepted
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T
innitus is a sound percept in the absence of a sound
source external to the body. Estimates of patients
with chronic tinnitus range from 5% to 15% in a
normal population.1,2 The available treatments for the man-
agement of patients with tinnitus are diverse, just like their
outcomes. Some treatments are efficient only for a small
group of patients but have no to little effect for most tinni-
tus sufferers. One way of attenuating tinnitus is by trying to
restore the sound input from the cochlea to the brain. This
may be done by commonly used devices such as hearing
aids or cochlear implants3 or with a specific tinnitus
masker. Other tinnitus treatments are removal of earwax,
middle-ear drug application, oral medication, brain surgery,
brain stimulation, and counseling therapies.4-7 The range of
treatment shows that there is no universal treatment for tin-
nitus at this moment. Therefore, tinnitus management often
focuses on how the patient handles his or her tinnitus.
Tinnitus can be masked with a sound.8-11 When this
masker sound stops, the tinnitus may temporarily reduce or
even temporarily become absent. This phenomenon is
referred to as ‘‘residual inhibition’’ and lasts seconds to
minutes.12 Tinnitus Care (London, UK) produces a pure-
tone phase-shift device that tries to elongate the residual
inhibition effect by shifting the phase of a pure-tone stimu-
lus. It is a noninvasive tinnitus therapy aimed at inhibiting
the tinnitus by presenting a specially synthesized sound for
30 minutes by headphones. The theory behind this device is
based upon sound cancellation. In sound cancellation, a
sound wave is generated with the same amplitude and fre-
quency, however with an inverted phase to the original
sound, so the original sound and the generated sounds
cancel each other out. Tinnitus is a patient’s endogenous
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wave and may be cancelled by negating the cortical per-
ception of tinnitus. The theory thus assumes that the tinni-
tus is perceived as a sound wave with a constant phase and
that optimal suppression occurs with a tone with a phase
shift of 180 degrees relative to the ‘‘endogenous wave.’’
However, the sound-wave phase of the tinnitus, if any, is
not known, and therefore the device is equipped with a 6-
degree phase shift every 30 seconds. This phase-shift
sound therapy essentially aims to elongate the period of
residual inhibition.13 In the United States and Belgium,
pilot studies with the phase-shift device (also: phase-out
device) have been performed with mixed results.13-15
Lipman and Lipman13 compared a sound generated by the
audiometer with a phase-shift sound generated with the
phase-shift device in a single-blind study. They showed an
improvement of at least 1 grade in the Tinnitus Handicap
Inventory (THI) questionnaire in 42% of the subjects and a
mean reduction of 9.2 dB in the tinnitus loudness match.
Vermeire et al15 evaluated the phase-shift treatment for a
week. If a positive effect was noticed, the device was
given to the patient for 6 weeks. In contrast, Meeus et al14
found no effect of the phase-shift therapy, comparing
patients with tinnitus resembling a pure-tone noise and
with tinnitus resembling narrow-band noise.
Because of these mostly promising results, we per-
formed a randomized double-blind crossover study to eval-
uate this new treatment according to consort statements.16
We compared the effect of the phase-shift therapy with
that of a nonshifting pure-tone control therapy. To achieve
well-controlled results and to keep the burden for a subject
acceptable, we chose to give each treatment throughout 1
week, taking into account that in a previous study,15
effects were already noticeable after 1 week of treatment
in patients with pure-tone tinnitus. To evaluate the effect
of the phase shift, a tinnitus-matched pure tone without
phase shifts was presented as control treatment. With this
design, we specifically test the effect of the phase shifts in
the tone stimulus.
Material and Methods
We performed a randomized double-blind crossover effi-
cacy study, in which each participant underwent a phase-
shift treatment and a control treatment. The treatments
started 1 month apart. This study was approved by the
Medical Research Ethics Committee of the University
Medical Center Groningen.
Sample Size
To determine the sample size, the 1.5-decrease in tinnitus
loudness (from 6.4 to 4.9, standard deviation 2.2) on a 10-
point visual analog scale was used, which was described by
Vermeire et al.15 While testing 2-sided with a = .05 and
80% power, it was found that 19 patients would be needed
to obtain significance, in a crossover randomized control
study design.
Randomization and Blinding
The order of the treatments was randomized across the sub-
jects: 13 subjects received phase shift as their first treat-
ment, and 12 started with the control treatment. Before the
study started, an independent audiologist randomized the
subject numbers by a select allotment. Stratification was not
applied in the randomization. The treatment settings were
identical in every way, except for 2 identical laptops, 1 deli-
vering a phase-shifted signal and the other a non-phase-
shifted control tone. The treatment and control laptops were
marked by letters A and B on the bottom, respectively. This
indication was blind to the subject and to the examiner. The
laptop was placed in the audiometric room by an indepen-
dent audiologist, prior to the entry of the subject and the
examiner.
Participants
Twenty-five patients were recruited, all having tinnitus that
was continuously present and resembled a pure tone. Their
hearing thresholds at the standard audiometric frequencies
(250-8000 Hz) were all <60 dB hearing level (HL).
Pregnant subjects or subjects with acousticus neurinoma,
aortic tract stenosis, or pulsatile tinnitus were excluded. All
subjects consulted our clinic for tinnitus as their primary
complaint.
Intervention
The intervention treatment consisted of 3 sessions (Figure 1).
The sessions took place within 1 week on Monday morning,
Wednesday morning, and Friday morning, in a large sound-
isolated room that is normally used for audiometric testing.
Each session started with a tinnitus-matching procedure, in
which the subject matched an external pure tone in frequency
and loudness to his or her tonal tinnitus for at least 3 times.
The median values were used as the best tinnitus match. The
matched frequency and intensity were used to generate the
treatment tone. The frequency-matched and loudness-matched





Figure 1. Timeline of the double-blind crossover treatment design for each subject. Treatments 1 and 2 were separated by 1 month; each
treatment consisted of 3 sessions. Questionnaires were filled out 3 times (Q). Tinnitus loudness and pitch match was performed 8 times
(arrows). Tinnitus loudness and annoyance was rated daily for 4 weeks.
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tone was presented on the tinnitus ear for 30 minutes, while
the phase of this pure-tone stimulus was shifted by 6 degrees
every 30 seconds. During the treatment, the subject was free to
do some reading.
All stimuli were controlled via an IBM Thinkpad Lenovo
R60e laptop using the Tinnitus Control, Inc (London, UK)
software. The frequency could be set from 100 to 13,000
Hz in 10-Hz steps for 100 to 1000 Hz and 100-Hz steps for
1000 to 13,000 Hz. The intensity could range from 0 to 110
dB HL with 1-dB increments. The laptop was connected to
a phase-shift sound generator (Tinnitus Care), which deliv-
ered its stimuli through Sony MDR-V600 headphones. All
equipment was provided by Tinnitus Control, Inc.
Control
The control treatment was identical to the intervention treat-
ment, except that the stimulus consisted of a pure tone with-
out phase shifting. A separate laptop was used, with an
appearance that was identical to that of the intervention
laptop. The sound generator used for the control treatment
was the same as that of the intervention. The software for
the control treatment was developed by the manufacturer of
the phase-shift sound generator (Tinnitus Care). The appear-
ance and user interface of this program was identical to that
of the computer program used for the intervention. Thus,
the investigator and the patient could not distinguish the
hardware and software used for the investigational and con-
trol treatments, respectively.
Evaluation
The treatments were evaluated by an audiometric tinnitus
pitch and loudness match, subjective ratings of the tinnitus
loudness and annoyance, and questionnaires.
The tinnitus matching was performed before and after
each treatment with the same equipment that was used for
the treatments: a pure tone was matched in frequency and
loudness to the subject’s tinnitus.
Subjects kept a tinnitus diary in which they filled out a
daily rating for tinnitus loudness and tinnitus annoyance for
4 weeks. Subjects were instructed to rate their mean day-
time tinnitus in the evening. The score ranged from 0.0,
which represents the worst possible condition (unbearable
tinnitus), to 10.0, which corresponds to the best possible sit-
uation (no tinnitus). In addition to this daily rating, we also
asked them to provide ratings before the first treatment ses-
sion and immediately after each treatment session.
The evaluating questionnaires were the THI,17 the
Tinnitus Reaction Questionnaire (TRQ),18 the Hospital
Anxiety and the Depression Scale (HADS),19 and the
Maastricht Questionnaire (MQ) for vital exhaustion.20 The
questionnaires were filled out before the first treatment and
1 week after the end of each treatment (Figure 1).
The THI consists of 25 items to quantify the impact of
tinnitus on daily living. The responses to each of the 25
items are assessed by a 3-point scale (0 = no, 2 = some-
times, 4 = yes) and are summed to get the total score. The
score is interpreted in terms of handicap severity. Scores
ranging from 0 to 16 indicate no or slight handicap, 18 to
36 indicate mild handicap, 38 to 56 indicate moderate han-
dicap, 58 to 76 indicate severe handicap, and 78 to 100 indi-
cate catastrophic handicap.
The TRQ consists of 26 items and assesses tinnitus-
related distress. The responses to each of the 26 items are
evaluated by a 5-point Likert scale (0-4; 0 = not at all to 4
= almost all of the time) and are summed into a total score.
The HADS includes 2 subscales: anxiety and depression.
Both subscales consist of 7 items each. Subjects answer on
a 4-point Likert scale (0-3; 0 = not at all to 3 = most of the
time). Thus, scores could range from 0 to 21 for anxiety as
well as for depression. A subscale score .11 is considered
an indication of depression or anxiety. The combined score
of 16 or more is suggestive of depression and anxiety.
The MQ consists of 21 questions that assess the vital
exhaustion of individuals. Each question is rated from 0 to
2, which gives a total score ranging from 0 to 42.
Statistical Analyses
Statistical analyses were performed with PASW Statistics
18 (SPSS, Inc, an IBM Company, Chicago, Illinois). The
paired Wilcoxon signed ranks test was performed to evalu-
ate the effect of both treatments separately and the effect of
the phase-shift treatment over the control treatment. Pearson
correlation was performed to compare the individual effect
of both treatments.
Results
Patient distribution is shown in Figure 2. Of the 25 patients
who started the study, 3 did not complete the study. In 1 case,
the tinnitus had stopped before the first treatment. In the
second case, the tinnitus loudness increased during the treat-
ment, which led the patient to withdraw from the study. The
third patient decided not to complete the study because it was
too time-consuming. The median age of the remaining 22 par-
ticipants was 53 years (range, 41-68 years). There were 19
men and 3 women. The median tinnitus duration was 3 years
and 6 months, ranging from 8 months to 52 years. The tinnitus
was reported to be on the right side in 6 cases, on the left side
in 1 case, in both ears in 7 cases, and centrally localized in 8
cases. The average tinnitus frequency match was 6.6 kHz,
ranging from 1.3 to 12.5 kHz. None of the participants used
hearing aids or had equilibrium problems. Seven participants
had noise exposure prior to the onset of their tinnitus. The
hearing thresholds were 60 dB HL or better. Figure 3 displays
the audiometric characteristics of the subject group.
Figure 4 shows spectra of the control and treatment sti-
muli, respectively. The spectrum of the phase-shift treat-
ment stimulus is broader than that of the control treatment
stimulus, which is consistent with the presence of phase
shifts in the treatment stimulus.
To investigate the separate treatment effects, the differ-
ences between pretreatment and posttreatment measure-
ments were analyzed (Table 1). The only significant effect
was a reduction of the intensity of the tinnitus matching
tone in the case of the control treatment, from a median
310 Otolaryngology–Head and Neck Surgery 147(2)
value of 65.5 dB to 57 dB (paired Wilcoxon signed ranks
test [pWSRT], P = .002; Figure 5).
Consequently, the differences between the paired treat-
ment results were calculated (Table 2). The immediate
effect of the treatment on the perceptual characteristics of
the tinnitus was assessed by 3 measures: (1) a subjective
rating of the perceived loudness, (2) a subjective rating of
the tinnitus annoyance, and (3) the intensity of a tone that
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Figure 3. Box and whisker plots of the hearing thresholds on the audiometric frequencies. The boxes have lines at the lower quartile,
median, and upper quartile values; whiskers are at the extreme data values (within 1.5 times the interquartile range); outliers are denoted
by a ‘‘1’’. The bold lines connect the median values.
Figure 2. Flowchart of patient inclusion. Forty-three patients were screened; of the 25 who were enrolled, 3 dropped out and 22 (= 10 1
12) completed the study.
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was matched in loudness to the tinnitus. No significant
improvement was demonstrated. Other measures, such as
the tinnitus loudness and annoyance rating, filled in by the
subjects in a diary, showed no beneficial improvement after
the phase-shift treatment in comparison with the effect of
control treatment for individual subjects.
The TRQ, THI, HADS total, and MQ questionnaire
scores showed no significant treatment effect for either
treatment as well (Figure 6). Furthermore, the scores after
each treatment were not significantly different (Table 1).
Finally, the individual effects of the phase-shift treatment
and control treatment (ie, the score after a treatment minus
the score before the treatment) were visually analyzed in a
scatter plot to see if there were individuals in whom one of
the treatments performed better (Figure 7). This graph
shows that individual subjects who benefited from 1 treat-
ment also experienced relief from the other treatment (r =
0.89, P \ .001). This was also found for the THI and the
other questionnaires.
Discussion
The main result of our study is that the phase-shift treatment
did not have a significant beneficial group effect on tinnitus,
as far as this could be evaluated with questionnaires, audio-
logical matching procedures, and loudness and annoyance
ratings of tinnitus (Figures 4-6). Both the phase-shift and
the control treatments had effects in some patients.
However, when the phase-shift treatment was compared
with the control treatment, there were no significant differ-
ences in outcome (Tables 1 and 2). In addition, the outer
ranges of the confidence intervals indicate that even in
higher numbered future studies, a clinical meaningful effect
is not to be expected.
Our control treatment consisted of a pure-tone stimulus.
This does not imply that we think that the pure tone has no
effect on tinnitus; we therefore did not use the term placebo.
Rather, our study was designed to investigate whether the
small phase shifts in the treatment tone have a specific effect
on tinnitus. None of the outcome measures suggests any addi-
tional positive effect of the phase-shifting technique.
Nevertheless, both treatments changed the audiological
and questionnaire outcomes in individual patients. For
example, in 1 patient, the THI and TRQ score improved by
more than 30 points. Thus, the phase-shift and control treat-
ments may possibly have a positive effect in a selected
patient population. Criteria on how to select such patients
are, however, presently unknown, and additional research
would be necessary to investigate this.
The stimulus exposure time, which was chosen to be in
line with the expected residual inhibitory effect, is a limita-
tion of this study. We cannot rule out that longer exposures
could lead to an effect, possibly explained by a neuronal























Figure 4. Spectrum of the phase-shift stimulus and the pure-tone
control treatment stimulus. Here, the stimulation frequency was
set at 2000 Hz.
Table 1. Pretreatment Patient Characteristics and Effects of the Phase-Shift and Control Treatments






across Subjects P Value
Median and 95%
Confidence Intervals
Across Subjects P Value
Tinnitus loudness, dB HLa 55.5 (48.9, 168.1) –0.5 (–4.0, 10.0) .06 –2.5 (–4.1, 10.0) .002b
THI (0-100)a 33.0 (20.0, 143.8) –3.0 (–6,0, 11.8) .32 –4.0 (–6.0, 13.8) .06
TRQ (0-104)a 34.5 (16.8, 144.3) –1.5 (–6.1, 11.0) .16 –1.0 (–4.1, 11.0) .24
MQ (0-42)a 25.0 (21.9, 135.1) 0.0 (–2.0, 13.0) .61 0.0 (–2.0, 12.0) .97
HADS total (0-28)a 12.0 (4.9, 114.0) –2.0 (–3.5, 10.5) .12 0.0 (–5.0, 11.0) .18
Loudness rating (0.0-10.0) 5.0 (3.0, 15.0) 0.0 (0.0, 11.0) .33 0.0 (0.0, 11.0) .09
Annoyance rating (0.0-10.0) 6.0 (5.0, 16.0) 0.0 (0.0, 10.0) .55 0.0 (0.0, 10.8) .59
The second column shows the patient characteristics at the start of the study. The last columns show the effects of the 2 treatments, reported as median dif-
ference with the 95% confidence intervals across subjects. The effects were calculated as the score after treatment minus the score before treatment (thus a
negative effect denotes a lower score after the treatment). Analyses were performed using the paired Wilcoxon signed rank test. Abbreviations: HADS,
Hospital Anxiety and Depression Scale; HL, hearing level; MQ, Maastricht Questionnaire; THI, Tinnitus Handicap Index; TRQ, Tinnitus Reaction
Questionnaire.
aMeasurement/questionnaires with a positive value indicate increased severity.
bSignificant at the 5% (P = .05) level.
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plasticity mechanism leading to the inhibition of tinnitus.
On the other hand, this study does demonstrate that phase
shifting has no auxiliary residual inhibitory effect compared
with a non-phase-shifting pure-tone stimulus. We suggest
that the effects reported by other authors of nonrandomized
crossover designs may be biased by a placebo effect.
Choy et al21 hypothesized that the phase-shift treatment
would cancel out neuronal activity in the auditory cortex by
a mechanism similar to the acoustic cancellation by antipha-
sic sound. However, such cancellation is improbable for
neuronal signals. Note that our tinnitus subjects on average
had a tinnitus pitch that matched a tone of 6.6 kHz. Because
auditory neurons have negligible phase locking to tones
above 4 kHz (see, eg, Johnson22), the phase of the stimulus
tone will not be coded in the neural response, ruling out the
option of neuronal antiphasic cancellation. Thus, the neural
activity in response to the phase-shift tone presumably has
characteristics nearly identical to that of a pure tone, and as
a consequence, subjects do not hear the difference between
a pure tone and the phase-shift tone. This gave us the possi-
bility to set up a double-blind study. However, it also shows
that the physiological basis for an effect of the phase-shift
treatment remains unclear.
Other authors13,15,21 have reported more positive out-
comes of the phase-shift treatment. Like the present study,
Lipman and Lipman13 used a pure-tone stimulus as a con-
trol. This control condition was administered in the 2 weeks
prior to the phase-shift treatment, where its presentation was
nonrandomized and not blinded to the investigator.
Furthermore, they described an effect lasting up to 1 week.
Consequently, it cannot be dismissed that possible long-
term effects of the control condition could influence the test




Confidence Interval P Value
Tinnitus loudness, dB HLa 0.5 (–1.0, 14.1) .19
THIa 3.0 (–2.0, 16.0) .19
TRQa 0.0 (–1.3, 13.0) .82
MQa 0.0 (–1.0, 12.1) .51
HADS totala 0.0 (–1.5, 11.5) 1.00
Loudness rating 0.0 (–0.3, 10.0) .65
Annoyance rating 0.0 (–1.0, 10.6) .41
For each subject, the paired difference was calculated by subtracting the
effect of the control treatment from the effect of the phase-shift treatment.
The second column shows the median of the differences across subjects.
For the first 5 quantities in the first column (a), larger values correspond to
a poorer condition, whereas for the last 2 quantities, larger values corre-
spond to a better condition. Thus, a positive difference for the question-
naires or the tinnitus loudness match in the second column and a negative
difference for both ratings indicate a disadvantage of the phase-shift treat-
ment over the control treatment. Analyses were performed using the
paired Wilcoxon signed rank test. Abbreviations: HADS, Hospital Anxiety
and Depression Scale; HL, hearing level; MQ, Maastricht Questionnaire;
THI, Tinnitus Handicap Index; TRQ, Tinnitus Reaction Questionnaire.
P=.0017
Figure 5. Box and whisker plots showing the matched tinnitus
intensity before and after each treatment (third session). Only the
matched intensity for the control treatment was significant (*). The
boxes have lines at the lower quartile, median, and upper quartile



































Figure 6. Box and whisker plots of the Hospital Anxiety and the
Depression Scale (HADS), filled out at the start of the study and
after each treatment. No significant differences were found. The
boxes have lines at the lower quartile, median, and upper quartile
values; whiskers are at the extreme data values (within 1.5 times
the interquartile range); outliers are denoted by a ‘‘1’’.
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condition in this study. Vermeire et al15 lacked a control treat-
ment and included only those subjects who responded posi-
tively to a test with the phase-shifting device similar to our
testing situation. One could argue that the measured effects in
their selection procedure could for the most part be caused by
a placebo effect, which is strong in tinnitus therapies.9
Selectively proceeding with these positive subjects may further
enlarge the amount of placebo contributing to the measured
effect. Their treatment protocol differed also from ours and
Lipman and Lipman’s in that subjects could take the phase-out
device home for a longer period of time. Possibly, the long
take-home treatment period has a positive effect, explained by
neuroplasticity, and this could be a focus for further research.
Choy et al21 described a control setting in a part of their
combined study (n = 35). This crossover design was not
blinded or randomized. The time between the different treat-
ments was not mentioned, and only the phase-shift treatment
was applied at the tinnitus loudness, whereas the 2 control
treatments had a fixed loudness and were presented at 77-
dB loudness. This design may have resulted in a significant
placebo effect on the tinnitus.
To our knowledge, our study is the first double-blind cross-
over efficacy study of the phase-shift treatment. The main con-
clusion is that, on average, the phase shifting had no significant
effect on tinnitus. In individual patients, we did observe
changes during the phase-shift treatment period, but these
changes were similar to those of a pure-tone control treatment.
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